Notice2024-20883
Center for Scientific Review; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 13, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 178 (Friday, September 13, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 178 (Friday, September 13, 2024)]
[Notices]
[Pages 74969-74970]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-20883]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Pathophysiology of Eye Disease--2 Study
Section.
Date: October 9-10, 2024.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Plaza Hotel, 10 Thomas Circle NW, Washington,
DC 20005.
Meeting Format: In person.
Contact Person: Cibu Paul Thomas, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1011-H, Bethesda, MD 20894, (301)
402-4341, <a href="/cdn-cgi/l/email-protection#8ffbe7e0e2eefcecffcfe2eee6e3a1e1e6e7a1e8e0f9"><span class="__cf_email__" data-cfemail="c7b3afa8aaa6b4a4b787aaa6aeabe9a9aeafe9a0a8b1">[email protected]</span></a>.
Name of Committee: Social and Community Influences on Health
Integrated Review Group; Psychosocial Development, Risk and
Prevention Study Section.
Date: October 10-11, 2024.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency, Bethesda, One Bethesda Metro Center,
Bethesda, MD 20814.
Meeting Format: In person.
Contact Person: Anna L. Riley, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3114, MSC 7759, Bethesda, MD 20892, (301) 435-
2889, <a href="/cdn-cgi/l/email-protection#e193888d8498808f8fa1829293cf8f8889cf868e97"><span class="__cf_email__" data-cfemail="4f3d26232a362e21210f2c3c3d6121262761282039">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-NS-24-021: HEAL Initiative: Individual Differences in
Human Pain Conditions.
Date: October 10-11, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Westin Georgetown, 2350 M Street NW, Washington, DC
20037.
Meeting Format: In person.
Contact Person: Abu Saleh Mohammad Abdullah, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1003-L, Bethesda, MD 20892, (301)
827-4043, <a href="/cdn-cgi/l/email-protection#45242730242721302929242d6b242721302929242d052b2c2d6b222a33"><span class="__cf_email__" data-cfemail="0c6d6e796d6e687960606d64226d6e687960606d644c626564226b637a">[email protected]</span></a>.
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Behavioral Neuroendocrinology,
Neuroimmunology, Rhythms, and Sleep Study Section.
Date: October 10-11, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: John N. Stabley, Ph.D., Scientific Review
Officer, Center for
[[Page 74970]]
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 594-0566, <a href="/cdn-cgi/l/email-protection#41323520232d24382b2f012232336f2f28296f262e37"><span class="__cf_email__" data-cfemail="7c0f081d1e10190516123c1f0f0e52121514521b130a">[email protected]</span></a>.
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Cancer and Hematologic Disorders Study
Section.
Date: October 10-11, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Steven M. Frenk, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3141, Bethesda, MD 20892, (301)
480-8665, <a href="/cdn-cgi/l/email-protection#a5c3d7c0cbced6c8e5c8c4ccc98bcbcccd8bc2cad3"><span class="__cf_email__" data-cfemail="6b0d190e050018062b060a020745050203450c041d">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 10, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-20883 Filed 9-12-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 13, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.